Neurometrix Inc (NURO)

[Dell_Griffith]

Fibromyalgia is a 2-3 billion dollar market. The medications are tough to handle and can be hit and miss. From what I've read, this is a device that has, minimum, over 50% effectiveness. So, no side effects and no drug to take.

The market cap at $10.00 is 38 mill (3.8 mill shs O/S). If they can capture 100 mill of a 2-3 billion market, you're potentially looking at a $25-$30 stock, maybe more, with the right momentum, but it is AWFULLY difficult to get FDA approval, so that is HUGE. Add in that it bumped from $10 to $13.60 after hours in light trading.

It looks like you have all the factors here for the perfect storm, particularly now that it is at a price where the institutions can buy in.